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ABSTRACT  
Some Schiff base compounds derived from sulfonamide drug were synthesized by reaction of 4-
aminobenzenesulfonamide with aromatic aldehydes (2-hydroxy-1-naphthaldehyde, 3,4-dihydroxybenzaldehyde and 2-
hydroxy benzaldehyde) in good yields.  Characterization of synthesized compound was carried by elemental analysis, IR, 
1
H,
13
C, HSQC and HMBC- NMR spectroscopy. The synthesized compounds were screened for their antibacterial activity 
against Staphylococcus aureus, Streptococcus sp., Bacillus subtillus, Escherichia coli and  Klebsiella pneumonia. 
Additionally, the compounds were tested for antifungicidal activity against Candida krusei, Candida tropicalis, Aspergillus 
fumigates and Aspergillus niger.   
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INTRODUCTION  
Sulphonamides were the first drugs found to act selectively and could be used systematically as preventive and the 
therapeutic agents against various diseases [1]. In medicine, the term "sulfonamide" is sometimes used as a synonym for 
sulfa drug, a derivative or variation of sulfanilamide. The first sulfonamide was discovered in 1932[2]. The condensation 
products of sulpha drugs with aldehydes and ketones are biologically active [3,4].  
Schiff bases are used as pigments and dyes, catalysts, intermediates inorganic synthesis and as polymer stabilizers. A 
number of Schiff’s base molecules show biological activities including antibacterial, antifungal, antidiabetic, antitumour, 
antiproliferative, anticancer, anti-corrosion and anti-inflammatory activities [5-8]. Sulfa Schiff bases have been subject to 
thorough studies where a wide diversity of these derivatives have been prepared and used in various biological and 
pharmacological fields [9-11]. The aim of present work is to synthesis of some Schiff base derived from sulphonamide 
(Scheme1) and study the biological activity theoretically (Molecular modiling and in vitro antimicrobial activity. 
EXPERIMANTAL  
a- Physical mesurments 
Infrared spectra (IR) were recorded as KBr discs in the range of 4000-400 cm
-1
using FT-IR spectrophotometer Shimadzu 
model IR. Affinity-1 at the department of Chemistry, College of Education for pure sciences, University of Basrah, Iraq.  
1
H, 
13
C, Roesy, HSQC and HMBC  NMR  spectra were measured on a Brucker at 600 MHz, with TMS as internal reference at 
Konstanz  university, Germany.   Microanalysis for carbon, hydrogen and nitrogen were carried out by a Perkin-Elmer 
240B Elemental Analyzer.  Melting points were measured by a Philip Harris melting point apparatus and uncorrected. 
b- Synthesis 
General Synthesis of Schiff-bases5-7 
4–aminobenzenesulfonamide 1 (1.37, 2.00 mmol) and aromatic aldehydes (2-4) (2.1 mmol) were dissolved in  absolute 
ethanol followed by addition of catalytic amount of glacial acetic acid dropwise and the mixture was heated under reflux for 
4h. The reaction mixture was then cooled in an ice bath and the crude product thus obtained was collected by filtration, 
further purified by recrystallization from ethanol. 
4-{[(2-hydroxynaphthalen-1-yl)methylidene]amino}benzenesulfonamide 5 
Yield,82 %, as a yellow solid, M.p. =276-278
0
C,FT‐IR (KBr, ν, cm‐1): 3420-3335(OH, NH),3082-3063(CH-aromatic), 
1622(C=C), 1602(C=N).  
1
H NMR (600 MHz, DMSO-d6, δ, ppm):15.46(s,1H, OH), 9.69(s,1H, CH=N), 8.41‐7.01(m, 10H, 
Ar‐H), 7.47(s,2H, NH).13C NMR(600 MHz, DMSO-d6,δ, ppm): 171.5 (C-O), 156.9 (C=N), 147.2-109.3 (C-Ar).  
       Anal. for C17H14N2O3S(M.wt 326.3):Calc.C,62.51; H, 4.29; N, 8.58; Found: C, 62.24; H, 3.97; N, 8.31.  
4-[(3,4-dihydroxybenzylidene)amino]benzenesulfonamide 6 
Yield, 78% as a brown solid, M.p.=136-138 
0
C,FT‐IR (KBr, ν, cm‐1): 3417-3300(OH, NH), 3074-3052(CH-aromatic), 
1610(C=C), 1598(C=N).  
1
H NMR (600 MHz, DMSO-d6, δ, ppm):  9.71( s, 1H, CH=N), 8.41‐6.59 (m, 10H, Ar‐H). 
13
C 
NMR(600 MHz, DMSO-d6,δ, ppm): 162.5  (C=N), 155.3-116.0(C-Ar). 
 
       Anal. for C13H12N2O4S(M.wt 292.3):Calc. C, 53.36; H, 4.10; N, 9.59; Found: C, 52.98; H, 3.97; N, 9.31.  
4-[(2-hydroxybenzylidene)amino]benzenesulfonamide 7 
Yield,72% as a yellow solid, M.p. =222-224 
0 
C,FT‐IR (KBr, ν, cm‐1): 3400-3325(OH, NH) 3080-3067(CH-aromatic), 
1618(C=C), 1600(C=N).  
1
H NMR (600 MHz, DMSO-d6, δ, ppm):  8.97(s, 1H, CH=N), 8.52‐7.01 (m, 10H, Ar‐H). 
13
C 
NMR(600 MHz, DMSO-d6,δ, ppm): 170.2 (CH=N), 152.3-112.9 (C-Ar). 
       Anal. for C13H12N2O3S(M.wt 276.3):Calc. C,56.46; H, 4.34; N, 10.13; Found: C, 56.14; H, 3.97; N, 9.92.  
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Scheme 1: Preparation of some Schiff-base of sulphonamide 
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c- Antimicrobial activity 
The synthesized compounds were screened in vitro for their antibacterial activity against:Staphylococcus aureus, 
Streptococcus sp., Bacillus subtillus, Escherichia coli and Klebsiella pneumonia. Additionally, the compounds were tested 
also for antifungal activity against Candida albicans, Candida tropicalis, Aspergillus fumigates and Aspergillus niger using 
the paper disc-agar diffusion technique on Muller Hinton agar and Sabouraud dextrose agaras a culture media for 
antibacterial activity and antifungal activity, respectively [12]. The test compounds were dissolved in DMSO solvent and 
recommended concentrations (50, 100 and 200 μg/mL) were used in the disc-agar diffusion technique. Antibiotic drug 
Ampicillin and Nystatin were used as control for bacteria and fungi, respectively. Petri plates containing 20 mL of Mueller 
Hinton Agar were used for all the bacteria tested. Fungistrains were cultivated in Sabouraud dextrose agar. Sterile 
Whatman no. 1 filter paper disks (6mm in diameter) impregnated with the solution in DMSO of the test were placed on the 
Petri plates. A paper disk impregnated with dimethyl sulfoxide (DMSO) was used as negative control. The plates were 
incubated for 24 h at 37 
o
C in the case of bacteria and 72 h that 27 
o
C for fungi. The inhibition zone diameters were 
measured in millimeters. The bacteria and fungi were supplied from department of Microbiology, College of Veterinary 
Medicine, University of Basrah. 
RESULTS AND DISCUSSION  
Chemistry 
Treatment of 4–aminobenzenesulfonamide1 with three aldehyde derivatives (2-hydroxy-naphthaldehyde 2, 3,4-
dihydroxybenzaldehyde 3 and 2-hydroxybenzaldehyde 4 in ethanol and catalytic by 3-4 drops of glacial acetic acid under 
reflux afforded the desired imine derivatives 5-7 in 82, 78 and 72 % yields, respectively (Scheme 1).The structures of the 
synthesized compounds were assigned by the elemental analysis (CHN),IR and 
1
H, 
13
C and 2D NMR. The IR spectra 
confirm the presence of the azomethine group (-CH=N) stretching with a sharp region for compounds 5-7 at 1602,1598 
and 1600 cm
-1
, respectively. In addition, the bands at the region 1622-1610 cm
-1
 were assigned to the C=C aromatic 
group. In the 
1
H NMR spectra of compounds 5-7, the singlets at δ9.69, 9.71 and 8.97 ppm  respectively, were assigned for 
the imine protons (CH=N). The multiplets at the regions δ 8.52-6.59 ppm were attributed to the aromatic protons. 
In the 
13
C NMR spectra of compounds 5-7, the resonances at δ155.3-109.3 ppm  were assigned for the aromatic carbon 
atoms (C-Ar).  The spectra revealed the presence of CH=N group around 156.9, 162.5 and 170.2 ppm, Figures 1-3 and 
6,9,11. 
 
Fig. 1: 
1
H NMR spectroscopy of compound 5 
 
Fig. 2:
1
H NMR spectroscopy (expantion) of compound 5 
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Fig. 3: 
13
C NMR spectroscopy of compound 5 
The 
1
H, 
13
C HSQC NMR spectrum of Schiff base 5 showed a cross peak at δH/δC = 9.70/156.9 ppm due to azomethine 
group (N=CH), Thus, the correlation of protons and carbon in aromatic rings such as  δH/δC = 8.52/121.0, 7.95/138.0 ppm 
and other positions can be assigned to the protons and carbon atoms of the aromatic ring , Table 1,  Figure 4. 
Table (1):  HSQC data for compound 5  
Compound 
1
H (ppm) 
13
C(ppm) Assignment 
 
OH
NSNH
2
OO
C H
4
-
2
-
6
-
1
-
1
2 3
4
4a
5
67
8
8a
3
-
5
-
 
9.70 
8.50 
7.95 
7.93 
7.81 
7.80 
7.55 
7.38 
7.00 
156.9 
121.0 
138.0 
128.0 
121.5 
130.0 
129.0 
125.0 
122.0 
C,H (CH=N)
 
C,H (5)
 
C,H (4) 
C,H (3
- 
, 5
-
) 
C,H (2
- 
, 6
-
)) 
C,H (7) 
C,H (8) 
C,H (6) 
C,H (3) 
 
 
Fig. 4: HSQC- NMR spectroscopy of compound 5 
The gradient‐selected 1H,13C, HMBC NMR spectrum  of compound 5 revealed two 1,3JC,H . Thus, the imino proton (CH=N) 
at δ9.70 ppm showed two 
1,3
JC,H correlations: first one with C-1 of the naphthyl ring at δ160.3 ppm, the second correlation 
with the aromatic carbon atom C-6’ at δ 109.3 ppm and the last one with the aromatic carbon atom C-1’ at δ147.2 ppm. 
Othercorrelations between protons  and carbon atoms can be assigned in Figure 5. 
The HSQC and HMBC-NMR Spectra of compounds 6 and 7 were supported the structures of synthesized compounds, 
Figures 7,8,10 and11. 
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Fig. 5: HMBC- NMR spectroscopy of compound 5 
 
Fig. 6: 
1
H NMR spectroscopy of compound 6 
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Fig. 7: HSQC- NMR spectroscopy of compound 2 
 
Fig. 8: HMBC- NMR spectroscopy of compound 2 
 
Fig. 9: 
1
H NMR spectroscopy of compound 3 
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Fig. 10: 
13
C NMR spectroscopy of compound 3 
 
Fig. 11: HSQC- NMR spectroscopy of compound 3 
 
Fig. 12: HMBC- NMR spectroscopy of compound 3 
Antimicrobial activity 
The studied compounds have been evaluated in vitro for their antibacterial and antifungal activities, using the paper disc-
agar diffusion technique [12] by measuring the inhibition zone in mm. Antibiotic drug ampicillin and Nystatin were used  as 
control for bacteria and fungi, respectively. The antibacterial activity of the synthesized compounds were tested against 
three Gram positive bacteria (Staphylococcus aureus,Streptococcus sp., Bacillus subtillus) and two Gram negative 
bacteria (Escherichia coli and Klebsiella pneumonia) at a concentration of 50, 100 and 200μg/ml using DMSO as a 
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solvent, which not effected in the growth of microbes. Mueller Hinton agar and Sabouraud dextrose agar were used as 
culture media for antibacterial and antifungal activity respectively. The results of the antimicrobial activity are shown in 
Table (1). 
The screening results indicate that the activity of compounds increases with an increase in the concentration of the 
solutions. The synthesized compound 1 show high activity against E.coli and Streptococcus spp additionally, the 
compound 1 also exhibit high biological activity against all tested fungi. Whereas the compound 2 show relatively  
a good activity against E.coli and all fungi. On the other hand, the compound 3 also show a good biological activity against 
E.coli and high antifungal activity against the Candida tropicalis, and Aspergillus niger, Table 1. 
Concerning to these findings, the possible explanations of our results attribute to the fact that different antibiotics, chemical 
compounds and drugs have different modes of action, owing to the nature of their structure and degree of attraction to 
certain objective sites within bacterial and fungi cells walls and membranes. 
Table 1: Microbial activities of the Schiff-base derivatives of sulphonamide drug 
Diameter of inhibition zone in mm for different microbial species 
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